Evidence map›Paper›PMID 32476905›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2018

Circulatory TGF-beta1 is significantly higher in early stage of pulmonary sarcoidosis.

Mehdi Mirsaeidi, Hesham R Omar, Andrew Calzadilla, Ahmad El Khatib, Philip Whitney, Nadera Sweiss, Daniel Culver, Michael Campos, Robert Baughman, Roberto Machado

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Immune mechanisms in fibrotic pulmonary sarcoidosis.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Mehdi MirsaeidiDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Miami, FL, USA.
Hesham R OmarInternal Medicine Department, Mercy Medical Center, Iowa, USA.
Andrew CalzadillaDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Miami, FL, USA.
Ahmad El KhatibDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Miami, FL, USA.
Philip WhitneyDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Miami, FL, USA.
Nadera SweissDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, IL, USA.
Daniel CulverDepartment of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic, Cleveland, OH, USA.
Michael CamposDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Miami, FL, USA.
Robert BaughmanDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Cincinnati, OH, USA.
Roberto MachadoInternal Medicine Department, Mercy Medical Center, Iowa, USA.
University of Miami · USCleveland Clinic · USUniversity of Cincinnati · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

and VEGFFGFgrowth factorsarcoidosisTGF-β1

Identifiers

PMID32476905
PMCPMC7170164
OpenAlexW2902482139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.